SILO

1.7109.04%
DE

Daniel E. Ryweck

Chief Financial Officer

Mr. Daniel E. Ryweck, also known as Dan, serves as Chief Financial Officer at Silo Pharma, Inc. since September 27, 2022. Mr. Ryweck served as the Chief Financial Officer at Sun BioPharma, Inc. until October 1, 2015. Mr. Ryweck has served as the Chief Compliance Officer of Mill City Ventures III Ltd. He served as the Chief Financial Officer of Cimarron Medical, Inc. From June 2015 to September 2015, he served as an Interim Chief Financial Officer of Sun BioPharma Inc. guiding that company through a reverse merger. Since 2000, he has maintained an individual accounting practice in the Minneapolis, Minnesota area. He served as a Director at KonaTel, Inc. (Dala Petroleum Corp.) from July 6, 2016 to August 31, 2017. Mr. Ryweck holds a Bachelor of Science degree in Accounting from the Carlson School of Management at the University of Minnesota.

公司職務